Association between factor XIII single nucleotide polymorphisms and aneurysmal subarachnoid hemorrhage: Clinical article

Journal of Neurosurgery

Volumn 110, Issue 3, 2009, Pages 475-481

  Ladenvall, Claes ^a,b   Csajbok, Ludvig ^b   Nylén, Karin ^a   Jood, Katarina ^a   Nellgård, Bengt ^b   Jern, Christina ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Fibrinolysis; Genetics; Polymorphism; Subarachnoid hemorrhage

Indexed keywords

NIMODIPINE; TRANEXAMIC ACID; BLOOD CLOTTING FACTOR 13;

ADULT; AGE DISTRIBUTION; ALLELE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ARTICLE; BLOOD CLOTTING FACTOR 13 GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBRINOLYSIS; GENE; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHY; GLASGOW OUTCOME SCALE; HAPLOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PLASMINOGEN ACTIVATOR INHIBITOR 1 GENE; PRIORITY JOURNAL; RISK; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SUBARACHNOID HEMORRHAGE; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR GENE; TISSUE PLASMINOGEN ACTIVATOR GENE; ANEURYSM RUPTURE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR;

ANEURYSM, RUPTURED; FACTOR XIII; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SUBARACHNOID HEMORRHAGE;

EID: 63849144612     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2008.7.JNS08272     Document Type: Article

References (37)

1. Ariens RA, Lai TS, Weisel JW, Greenberg CS, Grant PJ: Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 100:743-754, 2002
2. Bass R, Ellis V: Cellular mechanisms regulating non-haemostatic plasmin generation. Biochem Soc Trans 30:189-194, 2002
3. Benchenane K, Lopez-Atalaya JP, Fernandez-Monreal M, Touzani O, Vivien D: Equivocal roles of tissue-type plasminogen activator in stroke-induced injury. Trends Neurosci 27: 155-160, 2004 (Pubitemid 38251516)
4. Catto AJ, Kohler HP, Bannan S, Stickland M, Carter A, Grant PJ: Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage. Stroke 29:813-816, 1998 (Pubitemid 28173407)
5. Corral J, Iniesta JA, Gonzalez-Conejero R, Villalon M, Vicente V: Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage. Blood 97:2979-2982, 2001
6. Elbaz A, Poirier O, Canaple S, Chedru F, Cambien F, Amarenco P: The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood 95:586-591, 2000 (Pubitemid 30041674)
7. Endler G, Funk M, Haering D, Lalouschek W, Lang W, Mirafzal M, et al: Is the factor XIII 34Val/Leu polymorphism a protective factor for cerebrovascular disease? Br J Haematol 120:310-314, 2003 (Pubitemid 36194183)
8. Eriksson P, Kallin B, van't Hooft FM, Bavenholm P, Hamsten A: Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A 92:1851-1855, 1995
9. Feigin VL, Rinkel GJ, Lawes CM, Algra A, Bennett DA, van Gijn J, et al: Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 36:2773-2780, 2005
10. Gaist D, Vaeth M, Tsiropoulos I, Christensen K, Corder E, Olsen J, et al: Risk of subarachnoid haemorrhage in first degree relatives of patients with subarachnoid haemorrhage: follow up study based on national registries in Denmark. BMJ 320:141-145, 2000 (Pubitemid 30179361)
11. Gemmati D, Serino ML, Ongaro A, Tognazzo S, Moratelli S, Resca R, et al: A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases. Am J Hematol 67:183-188, 2001 (Pubitemid 32538617)
12. Ikeda K, Asakura H, Futami K, Yamashita J: Coagulative and fibrinolytic activation in cerebrospinal fluid and plasma after subarachnoid hemorrhage. Neurosurgery 41:344-350, 1997 (Pubitemid 27327496)
13. Jood K, Ladenvall P, Tjarnlund-Wolf A, Ladenvall C, Andersson M, Nilsson S, et al: Fibrinolytic gene polymorphism and ischemic stroke. Stroke 36:2077-2081, 2005 (Pubitemid 41429223)
14. Krischek B, Inoue I: The genetics of intracranial aneurysms. J Hum Genet 51:587-594, 2006 (Pubitemid 44048691)
15. Ladenvall P, Nilsson S, Jood K, Rosengren A, Blomstrand C, Jern C: Genetic variation at the human tissue-type plasminogen activator (tPA) locus: haplotypes and analysis of association to plasma levels of tPA. Eur J Hum Genet 11:603-610, 2003 (Pubitemid 37038775)
16. Mizoi K, Yoshimoto T, Takahashi A, Fujiwara S, Koshu K, Sugawara T: Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. J Neurosurg 78:430-437, 1993 (Pubitemid 23073213)
17. Mosher DF, Schad PE: Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa. J Clin Invest 64:781-787, 1979
18. Nina P, Schisano G, Chiappetta F, Luisa Papa M, Maddaloni E, Brunori A, et al: A study of blood coagulation and fibrinolytic system in spontaneous subarachnoid hemorrhage. Correlation with hunt-hess grade and outcome. Surg Neurol 55:197-203, 2001 (Pubitemid 32453178)
19. Nylen K, Csajbok LZ, Ost M, Rashid A, Blennow K, Nellgard B, et al: Serum glial fibrillary acidic protein is related to focal brain injury and outcome after aneurysmal subarachnoid hemorrhage. Stroke 38:1489-1494, 2007 (Pubitemid 46684150)
20. Peltonen S, Juvela S, Kaste M, Lassila R: Hemostasis and fibrinolysis activation after subarachnoid hemorrhage. J Neurosurg 87:207-214, 1997 (Pubitemid 27349104)
21. Procyk R, Adamson L, Block M, Blomback B: Factor XIII catalyzed formation of fibrinogen-fibronectin oligomers - a thiol enhanced process. Thromb Res 40:833-852, 1985 (Pubitemid 16170416)
22. Razzaq TM, Bass R, Vines DJ, Werner F, Whawell SA, Ellis V: Functional regulation of tissue plasminogen activator on the surface of vascular smooth muscle cells by the type-II transmembrane protein p63 (CKAP4). J Biol Chem 278:42679-42685, 2003 (Pubitemid 37310542)
23. Reiner AP, Schwartz SM, Frank MB, Longstreth WT Jr, Hindorff LA, Teramura G, et al: Polymorphisms of coagulation factor XIII subunit A and risk of nonfatal hemorrhagic stroke in young white women. Stroke 32:2580-2586, 2001
24. Roos YB, Levi M, Carroll TA, Beenen LF, Vermeulen M: Nimodipine increases fibrinolytic activity in patients with aneurysmal subarachnoid hemorrhage. Stroke 32:1860-1862, 2001 (Pubitemid 32772220)
25. Ruigrok YM, Rinkel GJ, Wijmenga C: Genetics of intracranial aneurysms. Lancet Neurol 4:179-189, 2005
26. Schroeder V, Chatterjee T, Kohler HP: Influence of blood coagulation factor XIII and FXIII Val34Leu on plasma clot formation measured by thrombelastography. Thromb Res 104:467-474, 2001 (Pubitemid 34086943)
27. Slowik A, Dziedzic T, Pera J, Figlewicz DA, Szczudlik A: Coagulation factor XIII VaI34Leu polymorphism in patients with small vessel disease or primary intracerebral hemorrhage. Cerebrovasc Dis 19:165-170, 2005 (Pubitemid 40754334)
28. Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989, 2001 (Pubitemid 32289743)
29. Tjarnlund A, Andersson M, Jood K, Ladenvall P, Jern C: Rapid genotyping of haemostatic gene polymorphisms using the 5′ nuclease assay. Thromb Haemost 89:936-942, 2003 (Pubitemid 36603436)
30. van Gijn J, Rinkel GJ: Subarachnoid haemorrhage: diagnosis, causes and management. Brain 124:249-278, 2001
31. Vergouwen MD, Frijns CJ, Roos YB, Rinkel GJ, Baas F, Vermeulen M: Plasminogen activator inhibitor-1 4G allele in the 4G/5G promoter polymorphism increases the occurrence of cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke 35:1280-1283, 2004 (Pubitemid 38697443)
32. Voetsch B, Loscalzo J: Genetic determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol 24:216-229, 2004 (Pubitemid 38197572)
33. Wang W, Boffa MB, Bajzar L, Walker JB, Nesheim ME: A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor. J Biol Chem 273:27176-27181, 1998 (Pubitemid 28500426)
34. Wilhelmsen L, Johansson S, Rosengren A, Wallin I, Dotevall A, Lappas G: Risk factors for cardiovascular disease during the period 1985-1995 in Goteborg, Sweden. The GOT-MONICA Project. J Intern Med 242:199-211, 1997
35. Wilson JT, Pettigrew LE, Teasdale GM: Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma 15:573-585, 1998
36. Wolf AT, Medcalf RL, Jern C: The t-PA -7351C>T enhancer polymorphism decreases Sp1 and Sp3 protein binding affinity and transcriptional responsiveness to retinoic acid. Blood 105:1060-1067, 2005
37. Yang Z, Eton D, Zheng F, Livingstone AS, Yu H: Effect of tissue plasminogen activator on vascular smooth muscle cells. J Vasc Surg 42:532-538, 2005 (Pubitemid 41323847)